Synonyms: CSF-1 | lanimostim | macrophage-CSF
Compound class:
Endogenous peptide in human, mouse or rat
Comment: M-CSF (CSF1) controls survival and differentiation of macrophages via activation of the CSF1 receptor (a receptor tyrosine kinase). The biologically active peptide is a homodimer or a heterodimer.
Pharmacological modulators of the CSF1/CSF1R axis, targeting tumour-associated macrophage (TAM) survival, are being developed for various solid tumour and hematological oncology indications as well as for autoimmune diseases.
Species: Human
|
References |
1. Kavanaugh WM. (2007)
Use of antibody to m-csf. Patent number: WO2007016240 A2. Assignee: Novartis Ag, Xoma Technology Ltd.. Priority date: 28/07/2005. Publication date: 08/02/2007. |